Skip to content
Screener

Enova International ENVA Change In Fair Value

Change In Fair Value at other companies

Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$12.16M
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$12.16M
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$3.52M
JPMorgan Chase logo
JPMorgan ChaseJPM
$346M-17.2%
QCR Holdings logo
QCR HoldingsQCRH
-$462.75K-162%
QCR Holdings logo
QCR HoldingsQCRH
-$462.75K-162%

Other financials

Income statement

See full
Revenue$928.9M+21.6%
Gross profit$568.1M+28.7%
Operating income$237.1M+28.8%
Net income$105.1M+38.0%
EPS (diluted)$4.00+39.9%

Balance sheet

See full
Cash & equivalents$122.2M+120%
Total debt$5.0B+26.3%
Total equity$1.5B+21.8%
Total assets$7.2B+26.2%

Cash flow

See full
Operating cash flow$544.0M+21.6%
CapEx$12.6M+12.4%
Free cash flow$531.4M+21.8%

Valuation

See full
Market cap$6.29B+141%
Enterprise value$11.21B+71.2%
P/E17.7×+7.5×
P/S1.8×+0.9×

Profitability

See full
Gross margin59.8%+2.4pp
Operating margin24%+1.3pp
Net margin10.3%+1.6pp
FCF margin56.7%+1.3pp

Returns & leverage

See full
Return on equity26.1%+4.5pp
Debt / equity3.4×+0.1×

Where this comes from

Reported directly by Enova International in its filing.

Tagged under the XBRL concept enva:ChangeInFairValue.

The source filing: Enova International’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 5:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-314590
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Revenue$928,927$764,043$1,804,069$1,509,584
Change in Fair Value(360,861)(322,585)(707,044)(641,944)
Net Revenue568,066441,4581,097,025867,640
Operating Expenses
Marketing203,557142,848392,972282,139
Operations and technology74,86463,648150,615126,110
General and administrative44,08040,50891,85882,972
Depreciation and amortization8,41810,34817,32720,409

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Enova International's change in fair value?
Enova International (ENVA) reported change in fair value of $360.86M in Q2 2026.
How has Enova International's change in fair value changed year-over-year?
Enova International's change in fair value increased by 11.9% year-over-year, from $322.59M to $360.86M.
What is the long-term trend for Enova International's change in fair value?
Over 4 years (2021 to 2025), Enova International's change in fair value has grown at a 63.8% compound annual growth rate (CAGR), from $183.67M to $1.32B.
What does change in fair value mean?
This metric represents the periodic adjustment to the carrying value of financial assets or liabilities measured at fair value through the income statement. It reflects unrealized gains or losses resulting from changes in market conditions, credit risk, or valuation models applied to the company's loan portfolios or financial instruments. Monitoring this figure is essential for understanding the volatility of the company's balance sheet and the underlying credit quality of its lending products.

Ask your AI about Enova International's change in fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude